About Us

Creative Proteomics is the Proteomics division of CD Inc, an integrated CRO company that provides a full range of drug development services, including Molecular Biology, Biochemistry, Systems Biology, Organic Chemistry, Genomics, Bioinformatics, Structural Biology, Preclinical and Clinical studies.

Creative Proteomics specializes in a full range of services to support various proteome-related researches from identification of single proteins to large-scale proteomic studies. We have one of the most advanced proteomics platforms in the world and our staff scientists are experienced proteomics professionals. We provide individualized solutions for proteome analysis of different samples including cell organelles, cells, tissues, organs, body fluids and other complex protein preparations. In addition, analyses of protein post-translational modifications such as phosphorylation and glycosylation are available.

Creative Proteomics has developed a comprehensive technology portfolio that guarantees the quality of our services in differential proteomics areas with biomarker validation in particular. Besides two-dimensional electrophoresis (2-DE), we use a streamlined chromatography strategy to efficiently separate intact proteins and enrich low-abundance proteins. In particular, MALDI-TOF-TOF and LC-MS are routinely used to process protein samples of low complexity; while multi-dimensional chromatographic separation (MDLC) plus mass spectrometry is used for samples of great complexity.

O      Protein and peptide separation
O      Protein difference analysis
O      Protein identification
O      De novo peptide sequencing
O      Protein post-translational modification analysis
O      Protein quantification analysis
O      Peptidomics (Serum Peptide Biomarker Discovery)
O      MALDI-MS imaging for tissue peptide markers
O      Amino acid sequencing